Close Menu

NEW YORK – With test volumes plummeting due to the SARS-CoV-2 pandemic, remote sampling approaches could allow labs to reach patients who are postponing routine medical care during the outbreak.

The lab industry has long been interested in remote sampling tools like dried blood spots due to their potential convenience and cost advantages. The ongoing COVID-19 crisis could drive further interest and adoption of such techniques, some industry observers suggested.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Sponsored by

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.